Diagnostics Marks 'NHS 70' With New UK Push On AMR
The National Health Service (NHS) came into being in the UK 70 years ago today, and to mark the occasion, NHS England and UK diagnostics stakeholders have officially launched a new prevention initiative: the UK AMR Diagnostic Collaborative. Its targeted actions and recommendations will help the NHS – and global systems – tackle the ever-larger-looming issue of antimicrobial resistance.
You may also be interested in...
During the annual BIO International conference in June, researchers from the UK – which has pushed antimicrobial resistance to front and center on the global stage – discussed ongoing efforts for incentivizing antibiotic discovery and development, and the challenges that remain when it comes to management and resolution of the world’s AMR crisis.
Changes are afoot for the four UK Diagnostic Evidence Co-operatives that help generate clinical and cost-effectiveness data for innovative IVDs. Companies worry it could mean diagnostic industry needs get lost among broad medtech targets. Also, a roundup of the British In Vitro Diagnostics Association's key priorities, including the EU IVD Regulation, procurement issues, antimicrobial resistance, and of course, Brexit, highlighted at the group's 2016 annual meeting.
In championing Forte Medical’s precision diagnostics technology to improve the quality of urine test samples, 2022 Rising Leader Giovanna Forte has often had to confront market access hurdles. It has not dented her drive to secure widespread adoption of money-saving and outcomes-boosting devices.